Latanoprost Stada

Latanoprost, the active ingredient in Latanoprost Stada, is a prostaglandin analog presented as eye drops for ocular use. It lowers intraocular pressure and is used to treat primary open-angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog that reduces intraocular pressure in glaucoma‑related conditions. - Primary open-angle glaucoma: lowers intraocular pressure to prevent optic nerve damage. - Ocular hypertension: reduces elevated eye pressure to lower risk of developing glaucoma. - Normal‑tension glaucoma: helps maintain target pressure levels despite normal baseline readings.

Latanoprost eye drops may cause a range of ocular reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual pigmentation change. - Eye irritation or foreign‑body sensation.

Serious or Rare Side Effects: - Severe eye inflammation (uveitis or iritis). - Allergic reaction: swelling, itching, or rash around the eye. - Vision loss: sudden decrease in visual acuity. - Ocular infection: signs of bacterial or fungal involvement.

Before using Latanoprost, consider the following safety measures. - Monitor intraocular pressure: schedule regular eye pressure checks. - Assess for ocular infections: discontinue if signs of infection appear. - Avoid contact lenses: remove lenses during treatment to reduce irritation. - Inform ophthalmologist of other eye medications: potential additive effects. - Store at room temperature: keep bottle in original packaging, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concomitant prostaglandin analog eye drops: may cause excessive pressure reduction. - Use with ocular anesthetics: increased risk of corneal toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may diminish Latanoprost efficacy. - Topical beta‑blockers: additive intraocular pressure‑lowering effect. - Systemic corticosteroids: may counteract pressure‑lowering action.